Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
FDA Approval of Respiratory Biosimilars—Turning the Tide of Cost‐Effectiveness?
FDA Approval of Respiratory Biosimilars—Turning the Tide of Cost‐Effectiveness?
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Ashley L. Miller
,
Charles A. Elmaraghy
,
Casey D. Curtis
,
Vinay K. Rathi
Format:
Artículo Open Access
Published:
Wiley
2026
Subjects:
Otolaryngology–Head and Neck Surgery
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1002/ohn.70227
Similar Items
Price and Adoption of Exhalation Delivery System With Fluticasone, 2018‐2023
by: Taylor S. Erickson, et al.
Published: (2025)
Availability and Pricing of Drugs Prescribed by Otolaryngologists Through a Direct‐to‐Consumer Pharmacy: Medicare Savings Implications
by: Taylor S. Erickson, et al.
Published: (2024)
Complications Associated with AMBU™ Scope Use: An FDA MAUDE Analysis
by: David R. Grimm, et al.
Published: (2024)
Cost‐Effectiveness Analysis of Operating Room and In‐Office Reconstruction of Skin Cancer Defects
by: Rahul K. Sharma, et al.
Published: (2024)
Rates and Outcomes of Head and Neck Cancer Among Patients With Primary Immunodeficiency Disorders
by: Talia A. Wenger, et al.
Published: (2026)